In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan Drug Master File in Korea (Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan. The MFDS reviews the Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan KDMF as part of the drug registration process and uses the information provided in the Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zomig, Zomigon, AscoTopand, Zomigoro, Zolmitriptan suppliers with KDMF on PharmaCompass.